136 related articles for article (PubMed ID: 36813059)
21. Amyotrophic Lateral Sclerosis Type 20 - In Silico Analysis and Molecular Dynamics Simulation of hnRNPA1.
Krebs BB; De Mesquita JF
PLoS One; 2016; 11(7):e0158939. PubMed ID: 27414033
[TBL] [Abstract][Full Text] [Related]
22. Mutations within the 5' region of FAS/CD95 gene in nodal diffuse large B-cell lymphoma.
Scholl V; Stefanoff CG; Hassan R; Spector N; Renault IZ
Leuk Lymphoma; 2007 May; 48(5):957-63. PubMed ID: 17487740
[TBL] [Abstract][Full Text] [Related]
23. EBV-positive HIV-associated diffuse large B cell lymphomas are characterized by JAK/STAT (STAT3) pathway mutations and unique clinicopathologic features.
Chapman JR; Bouska AC; Zhang W; Alderuccio JP; Lossos IS; Rimsza LM; Maguire A; Yi S; Chan WC; Vega F; Song JY
Br J Haematol; 2021 Sep; 194(5):870-878. PubMed ID: 34272731
[TBL] [Abstract][Full Text] [Related]
24. Determination of deleterious single-nucleotide polymorphisms of human LYZ C gene: an in silico study.
Venkata Subbiah H; Ramesh Babu P; Subbiah U
J Genet Eng Biotechnol; 2022 Jul; 20(1):92. PubMed ID: 35776277
[TBL] [Abstract][Full Text] [Related]
25. Mutations of the 5' noncoding region of the BCL-6 gene in primary bone lymphomas.
Gianelli U; Ponzoni M; Moro A; Alfano RM; Pellegrini C; Giardini R; Patriarca C; Armiraglio E; Bosari S; Parafioriti A; Coggi G
Ann Hematol; 2003 Nov; 82(11):691-5. PubMed ID: 14513282
[TBL] [Abstract][Full Text] [Related]
26. In Silico Prediction and Molecular Docking of SNPs in NRP1 Gene Associated with SARS-COV-2.
Özkan Oktay E; Kaman T; Karasakal ÖF; Enisoğlu Atalay V
Biochem Genet; 2024 Feb; 62(1):156-175. PubMed ID: 37296335
[TBL] [Abstract][Full Text] [Related]
27. Computational analysis of deleterious single nucleotide polymorphisms in catechol O-Methyltransferase conferring risk to post-traumatic stress disorder.
Chitrala KN; Nagarkatti P; Nagarkatti M
J Psychiatr Res; 2021 Jun; 138():207-218. PubMed ID: 33865170
[TBL] [Abstract][Full Text] [Related]
28. Characterization of DLBCL with a PMBL gene expression signature.
Duns G; Viganò E; Ennishi D; Sarkozy C; Hung SS; Chavez E; Takata K; Rushton C; Jiang A; Ben-Neriah S; Woolcock BW; Slack GW; Hsi ED; Craig JW; Hilton LK; Shah SP; Farinha P; Mottok A; Gascoyne RD; Morin RD; Savage KJ; Scott DW; Steidl C
Blood; 2021 Jul; 138(2):136-148. PubMed ID: 33684939
[TBL] [Abstract][Full Text] [Related]
29. Clinical aspects of TP53 gene inactivation in diffuse large B-cell lymphoma.
Voropaeva EN; Pospelova TI; Voevoda MI; Maksimov VN; Orlov YL; Seregina OB
BMC Med Genomics; 2019 Mar; 12(Suppl 2):35. PubMed ID: 30871527
[TBL] [Abstract][Full Text] [Related]
30. MYD88, CARD11, and CD79B Oncogenic Mutations are Rare Events in the Indian Cohort of De Novo Nodal Diffuse Large B-Cell Lymphoma.
Aggarwal V; Das A; Bal A; Srinivasan R; Das R; Prakash G; Malhotra P; Varma S
Appl Immunohistochem Mol Morphol; 2019 Apr; 27(4):311-318. PubMed ID: 29734251
[TBL] [Abstract][Full Text] [Related]
31. Development of
Baziyar P; Seyedalipour B; Hosseinkhani S; Nazifi E
Iran J Biotechnol; 2022 Oct; 20(4):e3178. PubMed ID: 38344317
[TBL] [Abstract][Full Text] [Related]
32. In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene.
Kamal MM; Mia MS; Faruque MO; Rabby MG; Islam MN; Talukder MEK; Wani TA; Rahman MA; Hasan MM
Sci Rep; 2024 May; 14(1):11607. PubMed ID: 38773180
[TBL] [Abstract][Full Text] [Related]
33. B-cell Function Gene Mutations in Diffuse Large B-cell Lymphoma: A Retrospective Cohort Study.
Xu PP; Zhong HJ; Huang YH; Gao XD; Zhao X; Shen Y; Cheng S; Huang JY; Chen SJ; Wang L; Zhao WL
EBioMedicine; 2017 Feb; 16():106-114. PubMed ID: 28153771
[TBL] [Abstract][Full Text] [Related]
34. Association of the suppressor of cytokine signaling 1 (SOCS1) gene polymorphisms with acute coronary syndrome in Mexican patients.
Vargas-Alarcon G; Posadas-Sanchez R; Posadas-Romero C; Gonzalez-Salazar C; Cardoso-Saldaña G; Martinez-Rios MA; Peña-Duque MA; Obil-Chavarria C; Perez-Mendez O; Fragoso JM
Mol Immunol; 2014 Nov; 62(1):137-41. PubMed ID: 24997329
[TBL] [Abstract][Full Text] [Related]
35. Impact of non-synonymous mutations on the structure and function of telomeric repeat binding factor 1.
Habib I; Khan S; Mohammad T; Hussain A; Alajmi MF; Rehman T; Anjum F; Hassan MI
J Biomol Struct Dyn; 2022; 40(19):9053-9066. PubMed ID: 33982644
[TBL] [Abstract][Full Text] [Related]
36. Characterization of genomic imbalances in diffuse large B-cell lymphoma by detailed SNP-chip analysis.
Scholtysik R; Kreuz M; Hummel M; Rosolowski M; Szczepanowski M; Klapper W; Loeffler M; Trümper L; Siebert R; Küppers R;
Int J Cancer; 2015 Mar; 136(5):1033-42. PubMed ID: 25042405
[TBL] [Abstract][Full Text] [Related]
37. Computational approach to unravel the impact of missense mutations of proteins (D2HGDH and IDH2) causing D-2-hydroxyglutaric aciduria 2.
Thirumal Kumar D; Jerushah Emerald L; George Priya Doss C; Sneha P; Siva R; Charles Emmanuel Jebaraj W; Zayed H
Metab Brain Dis; 2018 Oct; 33(5):1699-1710. PubMed ID: 29987523
[TBL] [Abstract][Full Text] [Related]
38. Diffuse large B-cell lymphoma and red cell autoimmunity: clinical role and pathogenesis.
Coombes C; Horikawa K; Jain S; Jiang S; Lim JH; Saxena K; Shadbolt B; Smyth L; Tobin J; Talaulikar D
Pathology; 2023 Feb; 55(1):104-112. PubMed ID: 36420560
[TBL] [Abstract][Full Text] [Related]
39. Oncogenically active MYD88 mutations in human lymphoma.
Ngo VN; Young RM; Schmitz R; Jhavar S; Xiao W; Lim KH; Kohlhammer H; Xu W; Yang Y; Zhao H; Shaffer AL; Romesser P; Wright G; Powell J; Rosenwald A; Muller-Hermelink HK; Ott G; Gascoyne RD; Connors JM; Rimsza LM; Campo E; Jaffe ES; Delabie J; Smeland EB; Fisher RI; Braziel RM; Tubbs RR; Cook JR; Weisenburger DD; Chan WC; Staudt LM
Nature; 2011 Feb; 470(7332):115-9. PubMed ID: 21179087
[TBL] [Abstract][Full Text] [Related]
40. Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P-Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases.
Dubois S; Viailly PJ; Bohers E; Bertrand P; Ruminy P; Marchand V; Maingonnat C; Mareschal S; Picquenot JM; Penther D; Jais JP; Tesson B; Peyrouze P; Figeac M; Desmots F; Fest T; Haioun C; Lamy T; Copie-Bergman C; Fabiani B; Delarue R; Peyrade F; André M; Ketterer N; Leroy K; Salles G; Molina TJ; Tilly H; Jardin F
Clin Cancer Res; 2017 May; 23(9):2232-2244. PubMed ID: 27923841
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
